Morgan Stanley Sticks to Their Buy Rating for YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (1558)
Morgan Stanley analyst Laurence Tam maintained a Buy rating on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (1558 – Research Report) yesterday and set a price target of HK$14.00.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Tam is a 2-star analyst with an average return of 1.5% and a 56.25% success rate.
Currently, the analyst consensus on YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H is a Moderate Buy with an average price target of HK$14.00.
The company has a one-year high of HK$15.54 and a one-year low of HK$7.92. Currently, YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H has an average volume of 6.91M.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Why One Analyst Thinks Tesla Could Dominate the 'Low-Altitude Economy'
"Look up, your ride has arrived," is a message some see as eventually landing in your inbox. 'In our view, the low altitude economy (LAE) may eventually vastly exceed the size of today's automotive market,' wrote Morgan Stanley analyst Adam Jonas in a research note earlier this week. That term refers to aerial commercial activities conducted within one mile of the earth's surface, airspace now sparsely occupied by helicopters and small drones. Analysts expect advancements in artificial intelligence and robotics to support the launch of new aircraft—notably, electric vertical take-off and landing (eVTOL) vehicles—with applications in areas like logistics/distribution, public security and emergency services, tourism, urban commuting, and intercity transportation. Morgan Stanley forecasts the total addressable 'Urban Air Mobility' (UAM) market will be valued at $1 trillion by 2040 and $9 trillion by 2050. Not everybody's expectations are quite that high: Bank of America recently estimated a market worth $23 billion by 2035. BofA expects adoption to remain relatively slow until at least that year, when it anticipates economies of scale and battery technologies to improve eVTOL cost and accessibility. Whatever the size of the pie, the companies vying for a slice of it include upstarts like Archer Aviation (ACHR), which is currently testing an eVTOL model and partnering with defense contractor Anduril to develop military applications, and Joby Aviation (JOBY), which is in the process of getting its air taxi certified for passenger rides. Morgan Stanley's Jonas thinks those companies could face formidable competition from Tesla (TSLA). The EV maker hasn't announced any intention to develop eVTOLs, but CEO Elon Musk has discussed the need for a homegrown low-altitude economy in the U.S. When Jonas, on Tesla's most recent earnings call, asked Musk for his thoughts on the U.S. and China's AI and robotics rivalry, Musk expressed concern about America's limited drone manufacturing capabilities. 'Any country that cannot manufacture its own drones is doomed to be the vassal state of any country that can,' he said, quoting X user "@naval." 'And we can't. America cannot currently manufacture its own drones.' Tesla, Jonas says, 'has a host of relevant skills to be a factor' in the commercial and military LAE, including its work in manufacturing, autonomy, electric motors and batteries, and robotics. Jonas estimates Tesla's share of a future $9 trillion UAM market could add between $100 and $1,000 to its share price. Tesla's work on autonomous vehicles could give it a leg up on LAE competitors. "Any advancement in the science of autonomous cars accelerates the advancement of autonomous aerial drones," Jonas wrote. Tesla is expected to launch its first robotaxi operation in Austin, Texas, later this month. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Insider
2 hours ago
- Business Insider
Kepler Capital Sticks to Its Buy Rating for Valmet Corp (0QIW)
In a report released on June 5, Johan Eliason from Kepler Capital maintained a Buy rating on Valmet Corp (0QIW – Research Report), with a price target of €34.00. The company's shares closed last Thursday at €28.94. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Eliason covers the Industrials sector, focusing on stocks such as Hexagon AB, Konecranes, and Valmet Corp. According to TipRanks, Eliason has an average return of 3.0% and a 47.74% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Valmet Corp with a €28.00 average price target. The company has a one-year high of €30.10 and a one-year low of €20.91. Currently, Valmet Corp has an average volume of 62.53K.
Business Insider
2 hours ago
- Business Insider
Kepler Capital Keeps Their Sell Rating on Unite Group plc (UTG)
In a report released on June 5, Julian Livingston-Booth from Kepler Capital maintained a Sell rating on Unite Group plc (UTG – Research Report), with a price target of p820.00. The company's shares closed yesterday at p840.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Livingston-Booth is a 4-star analyst with an average return of 3.5% and a 57.14% success rate. Livingston-Booth covers the Real Estate sector, focusing on stocks such as British Land Company plc, Land Securities Group plc REIT, and LondonMetric Property. Unite Group plc has an analyst consensus of Moderate Buy, with a price target consensus of p1,033.83.
